Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALC NASDAQ:DXCM NYSE:HCA NYSE:THC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALCAlcon$67.82-0.2%$73.36$61.83▼$92.55$33.53B0.932.58 million shs2.00 million shsDXCMDexCom$72.10+0.3%$63.58$54.11▼$89.98$27.82B1.47.01 million shs6.73 million shsHCAHCA Healthcare$394.40+0.5%$465.16$330.00▼$556.52$87.42B1.181.56 million shs1.11 million shsTHCTenet Healthcare$174.00-2.3%$194.07$146.60▼$247.21$14.97B1.31.77 million shs1.01 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALCAlcon0.00%+6.53%-10.60%-17.94%-22.52%DXCMDexCom0.00%+16.99%+14.99%-1.34%-15.07%HCAHCA Healthcare0.00%-6.69%-16.85%-26.00%+3.13%THCTenet Healthcare0.00%-11.40%-7.54%-24.21%+6.91%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALCAlcon$67.82-0.2%$73.36$61.83▼$92.55$33.53B0.932.58 million shs2.00 million shsDXCMDexCom$72.10+0.3%$63.58$54.11▼$89.98$27.82B1.47.01 million shs6.73 million shsHCAHCA Healthcare$394.40+0.5%$465.16$330.00▼$556.52$87.42B1.181.56 million shs1.11 million shsTHCTenet Healthcare$174.00-2.3%$194.07$146.60▼$247.21$14.97B1.31.77 million shs1.01 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALCAlcon0.00%+6.53%-10.60%-17.94%-22.52%DXCMDexCom0.00%+16.99%+14.99%-1.34%-15.07%HCAHCA Healthcare0.00%-6.69%-16.85%-26.00%+3.13%THCTenet Healthcare0.00%-11.40%-7.54%-24.21%+6.91%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALCAlcon 2.63Moderate Buy$85.1225.52% UpsideDXCMDexCom 2.92Moderate Buy$82.2114.02% UpsideHCAHCA Healthcare 2.63Moderate Buy$515.7730.78% UpsideTHCTenet Healthcare 2.86Moderate Buy$244.1640.32% UpsideCurrent Analyst Ratings BreakdownLatest ALC, DXCM, HCA, and THC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026HCAHCA Healthcare JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$535.00 ➝ $490.005/18/2026HCAHCA Healthcare Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)5/18/2026DXCMDexCom Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$100.00 ➝ $82.005/18/2026DXCMDexCom BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingUnderweight$67.00 ➝ $64.005/18/2026DXCMDexCom Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$100.00 ➝ $80.005/15/2026DXCMDexCom William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy5/12/2026ALCAlcon Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/11/2026DXCMDexCom BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$77.005/11/2026DXCMDexCom BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy5/8/2026ALCAlcon BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$90.00 ➝ $78.005/7/2026ALCAlcon Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$97.00 ➝ $86.00(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALCAlcon$10.40B3.22$5.49 per share12.36$44.75 per share1.52DXCMDexCom$4.66B5.97$2.77 per share26.04$7.66 per share9.41HCAHCA Healthcare$75.60B1.16$45.28 per share8.71($13.42) per share-29.39THCTenet Healthcare$21.31B0.70$27.75 per share6.27$77.93 per share2.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALCAlcon$980M$1.6640.8517.521.717.70%7.11%4.98%N/ADXCMDexCom$836.30M$2.3430.8123.871.1919.31%33.33%13.19%7/29/2026 (Estimated)HCAHCA Healthcare$6.78B$29.0813.5611.961.258.89%-295.93%11.21%7/24/2026 (Estimated)THCTenet Healthcare$1.41B$19.239.059.851.147.94%25.55%5.15%7/28/2026 (Estimated)Latest ALC, DXCM, HCA, and THC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026ALCAlcon$0.80$0.85+$0.05$0.39$2.64 billion$2.71 billion4/30/2026Q1 2026DXCMDexCom$0.47$0.56+$0.09$0.51$1.17 billion$1.19 billion4/30/2026Q1 2026THCTenet Healthcare$4.21$4.82+$0.61$8.01$5.39 billion$5.37 billion4/24/2026Q1 2026HCAHCA Healthcare$7.19$7.15-$0.04$7.15$19.09 billion$19.11 billion2/24/2026Q4 2025ALCAlcon$0.79$0.78-$0.01$0.44$2.71 billion$2.72 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthALCAlconN/AN/AN/AN/A4 YearsDXCMDexComN/AN/AN/AN/AN/AHCAHCA Healthcare$3.120.79%+30.19%10.73%6 YearsTHCTenet HealthcareN/AN/AN/AN/AN/ALatest ALC, DXCM, HCA, and THC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/24/2026HCAHCA Healthcarequarterly$0.780.72%6/16/20266/16/20266/30/20264/2/2026ALCAlconannual$0.280.43%5/6/20265/6/20265/7/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALCAlcon0.192.201.39DXCMDexCom0.421.951.64HCAHCA HealthcareN/A0.830.75THCTenet Healthcare1.961.361.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALCAlcon53.86%DXCMDexCom97.75%HCAHCA Healthcare62.73%THCTenet Healthcare95.44%Insider OwnershipCompanyInsider OwnershipALCAlcon1.52%DXCMDexCom0.28%HCAHCA Healthcare1.50%THCTenet Healthcare0.97%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALCAlcon25,942494.62 million487.10 millionOptionableDXCMDexCom11,000385.87 million384.79 millionOptionableHCAHCA Healthcare320,000221.84 million218.51 millionOptionableTHCTenet Healthcare99,00086.14 million85.30 millionOptionableALC, DXCM, HCA, and THC HeadlinesRecent News About These CompaniesJ.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)May 24 at 12:25 PM | theglobeandmail.comIs Tenet (THC) a Solid Growth Stock? 3 Reasons to Think "Yes"May 22 at 1:46 PM | zacks.comTenet Healthcare (THC) slides as investors weigh ongoing Leapfrog litigation headlines and post-earnings recalibrationMay 21 at 5:31 PM | quiverquant.comQInvestors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to KnowMay 21 at 10:01 AM | zacks.comHere's Why Tenet Healthcare (THC) is a Strong Momentum StockMay 20, 2026 | zacks.comGabelli Funds LLC Cuts Stock Holdings in Tenet Healthcare Corporation $THCMay 20, 2026 | marketbeat.comTenet, Leapfrog spar over legal fees in hospital ratings caseMay 19, 2026 | finance.yahoo.comIs Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?May 19, 2026 | zacks.comQ2 EPS Estimate for Tenet Healthcare Decreased by AnalystMay 19, 2026 | marketbeat.comTenet system asks court to make Leapfrog pay $10.5M in legal feesMay 19, 2026 | beckershospitalreview.comBThrivent Financial for Lutherans Has $12.17 Million Position in Tenet Healthcare Corporation $THCMay 19, 2026 | marketbeat.comWall Street Analysts Think Tenet (THC) Could Surge 26.16%: Read This Before Placing a BetMay 18, 2026 | zacks.comWhat is Zacks Research's Forecast for THC Q3 Earnings?May 18, 2026 | marketbeat.comIs Tenet Healthcare (THC) Stock Undervalued Right Now?May 15, 2026 | zacks.comConifer automation helps Tenet offset Q1 headwindsMay 13, 2026 | beckershospitalreview.comBTenet Healthcare Corporation (THC) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 13, 2026 | seekingalpha.comTenet Healthcare (NYSE:THC) Lowered to "Buy" Rating by Wall Street ZenMay 11, 2026 | marketbeat.comPrincipal Financial Group Inc. Sells 7,237 Shares of Tenet Healthcare Corporation $THCMay 10, 2026 | marketbeat.comTenet Healthcare Corporation (NYSE:THC) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 9, 2026 | marketbeat.comWhy Tenet Healthcare (THC) is a Top Value Stock for the Long-TermMay 8, 2026 | zacks.comSwedbank AB Buys 18,750 Shares of Tenet Healthcare Corporation $THCMay 8, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesHims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusBy Jessica Mitacek | May 8, 2026Did Qualcomm Just Put Apple in Check?By Jeffrey Neal Johnson | April 28, 2026Qualcomm’s 50% Surge: Bubble Territory or Breakout Moment?By Sam Quirke | May 4, 20263 Healthcare Stocks Set to Benefit From the One Big Beautiful BillBy Chris Markoch | May 10, 2026Qualcomm Stock Doubles: New Era? Or Another False Start?By Sam Quirke | May 13, 2026ALC, DXCM, HCA, and THC Company DescriptionsAlcon NYSE:ALC$67.82 -0.11 (-0.17%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$67.80 -0.02 (-0.03%) As of 05/22/2026 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.DexCom NASDAQ:DXCM$72.10 +0.20 (+0.28%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$72.59 +0.49 (+0.68%) As of 05/22/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.HCA Healthcare NYSE:HCA$394.40 +1.84 (+0.47%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$395.84 +1.44 (+0.36%) As of 05/22/2026 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.Tenet Healthcare NYSE:THC$174.00 -4.01 (-2.25%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$174.46 +0.47 (+0.27%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Palantir and Dell Build an AI OS for the Paranoid Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
